Microglia

• 

  Subject Areas on Research

  • A Brief Discussion on Lipid Activated Nuclear Receptors and their Potential Role in Regulating Microglia in Age-Related Macular Degeneration (AMD). 
  • A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models. 
  • APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. 
  • APOE genotype-specific differences in human and mouse macrophage nitric oxide production. 
  • APOE genotype-specific differences in the innate immune response. 
  • Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. 
  • Activated human microglia produce the excitotoxin quinolinic acid. 
  • Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. 
  • Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. 
  • An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage. 
  • An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. 
  • Androgen-mediated immune function is altered by the apolipoprotein E gene. 
  • Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. 
  • ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury. 
  • ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. 
  • Apolipoprotein E Exerts a Whole-Brain Protective Property by Promoting M1? Microglia Quiescence After Experimental Subarachnoid Hemorrhage in Mice. 
  • Apolipoprotein E isoform mediated regulation of nitric oxide release. 
  • Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. 
  • Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. 
  • Assessing activation states in microglia. 
  • Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. 
  • Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. 
  • CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. 
  • CNS inflammation and bone marrow neuropathy in type 1 diabetes. 
  • COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. 
  • Central immune overactivation in the presence of reduced plasma corticosterone contributes to swim stress-induced hyperalgesia. 
  • Characterization of NO and cytokine production in immune-activated microglia and peritoneal macrophages derived from a mouse model expressing the human NOS2 gene on a mouse NOS2 knockout background. 
  • Complement activation contributes to perioperative neurocognitive disorders in mice. 
  • Control protocol for robust in vitro glial scar formation around microwires: essential roles of bFGF and serum in gliosis. 
  • Controlled release of anti-inflammatory agent alpha-MSH from neural implants. 
  • Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. 
  • Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. 
  • Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18. 
  • Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. 
  • Different immune cells mediate mechanical pain hypersensitivity in male and female mice. 
  • Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. 
  • Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice. 
  • Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. 
  • Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. 
  • Dramatic increase in autism prevalence parallels explosion of research into its biology and causes. 
  • ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. 
  • Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. 
  • Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. 
  • Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. 
  • Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. 
  • Endogenous opioids and HIV infection. 
  • Environment matters: microglia function and dysfunction in a changing world. 
  • Ethanol induced changes in superoxide anion and nitric oxide in cultured microglia. 
  • Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-α secretion. 
  • Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. 
  • Function of microglia in organotypic slice cultures. 
  • Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma. 
  • Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity. 
  • Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. 
  • Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production. 
  • Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. 
  • Heterogeneity of microglial activation in the innate immune response in the brain. 
  • Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. 
  • Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. 
  • IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD. 
  • Immune heterogeneity in neuroinflammation: dendritic cells in the brain. 
  • Immunobiology of malignant astrocytomas. 
  • Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. 
  • Induction of nitric oxide in cultured microglia: evidence for a cytoprotective role. 
  • Induction of superoxide anion and nitric oxide production in cultured microglia. 
  • Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone. 
  • Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. 
  • Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice. 
  • K+ modulation of microglial superoxide production: involvement of voltage-gated Ca2+ channels. 
  • KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients. 
  • LRRK2 inhibition attenuates microglial inflammatory responses. 
  • Lacosamide improves outcome in a murine model of traumatic brain injury. 
  • Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. 
  • M1 and M2 immune activation in Parkinson's Disease: Foe and ally? 
  • Microglia and memory: modulation by early-life infection. 
  • Microglia and spinal cord synaptic plasticity in persistent pain. 
  • Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease. 
  • Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. 
  • Microglial Signaling in Chronic Pain with a Special Focus on Caspase 6, p38 MAP Kinase, and Sex Dependence. 
  • Microglial contribution to oxidative stress in Alzheimer's disease. 
  • Microglial dopamine receptor elimination defines sex-specific nucleus accumbens development and social behavior in adolescent rats. 
  • Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport. 
  • Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. 
  • Microglial oxyradical production: causes and consequences. 
  • Microglial reactions after subcutaneous formalin injection into the rat hind paw. 
  • Microglial-neuronal interactions during neurodegenerative diseases. 
  • Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. 
  • Neuroinflammation in Alzheimer's disease. 
  • Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. 
  • Optimized solubilization of TRIzol-precipitated protein permits Western blotting analysis to maximize data available from brain tissue. 
  • Overcoming endogenous constraints on neuronal regeneration. 
  • Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes. 
  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. 
  • Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice. 
  • Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. 
  • Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. 
  • Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration. 
  • Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. 
  • SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. 
  • Sex steroids, APOE genotype and the innate immune system. 
  • Sex-Dependent Glial Signaling in Pathological Pain: Distinct Roles of Spinal Microglia and Astrocytes. 
  • Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord. 
  • Suramin inhibits spinal cord microglia activation and long-term hyperalgesia induced by formalin injection. 
  • Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. 
  • TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation. 
  • TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice. 
  • Targeting microglial purinergic signaling to improve morphine analgesia. 
  • The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol. 
  • The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation. 
  • The immune system and developmental programming of brain and behavior. 
  • The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. 
  • The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion. 
  • Transcription factor p53 influences microglial activation phenotype. 
  • Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia. 
  • Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. 
  • beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. 
  • miR-21 improves the neurological outcome after traumatic brain injury in rats. 
  • p38 MAPK, microglial signaling, and neuropathic pain. 
  • p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. 
  • α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. 
• 

  Keywords of People

  • Bilbo, Staci D., Scholar In Residence of Psychology and Neuroscience, Psychology and Neuroscience
  • Ferreira, Paulo Alexandre, Associate Professor in Ophthalmology, Pathology
  • James, Michael Lucas, Associate Professor of Anesthesiology, Anesthesiology, Neuroanesthesia
  • Nackley, Andrea Gail, Associate Professor in Anesthesiology, Pharmacology & Cancer Biology
  • Shinohara, Mari L., Associate Professor of Immunology, Immunology
  • Terrando, Niccolò, Associate Professor in Anesthesiology, Cell Biology
  • Warner, David Samuel, Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology